| Income Statement for Salix Pharmaceuticals Ltd. (SLXP) | | | | After Hours: $ 5.85 |  -0.15 (-2.50%) | Volume: 1.64 k | 4:10 PM EDT Oct 10, 2008 | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | 235,792 | 208,533 | 154,903 | 105,496 | 55,807 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | (54,859) | (39,878) | (33,091) | (21,035) | (12,751) | | Gross Operating Profit | 180,933 | 168,655 | 121,812 | 84,461 | 43,056 | | | Selling/General/Admin Expense | (86,492) | (83,932) | (70,823) | (55,965) | (38,760) | | Research & Development | (71,947) | (47,917) | (34,647) | (20,366) | (23,654) | | EBITDA | 22,494 | 36,806 | 16,342 | 8,130 | (19,358) | | Depreciation & Amortization | (10,642) | (6,472) | (3,410) | (1,481) | (475) | | EBIT | 11,852 | 30,334 | 12,932 | 6,649 | (19,833) | | Interest Income | 3,326 | 2,552 | 1,222 | 598 | (268) | | Other Income, Net | - | - | - | - | - | | Total Income Avail For Interest Expense | 15,178 | 32,886 | (59,846) | 7,247 | (20,101) | | Interest Expense | - | - | - | - | - | | Pre-Tax Income | 15,178 | 32,886 | (59,846) | 7,247 | (20,101) | | Income Taxes | (6,953) | (1,376) | (739) | (408) | - | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | 8,225 | 31,510 | (60,585) | 6,839 | (20,101) | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | 8,225 | 31,510 | (60,585) | 6,839 | (20,101) | | | Normalized Income | 8,225 | 31,510 | 13,415 | 6,839 | (20,101) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | - | - | (74,000) | - | - | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | 8,225 | 31,510 | (60,585) | 6,839 | (20,101) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | 0.17 | 0.68 | -1.55 | 0.19 | -0.61 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | 0.17 | 0.68 | -1.55 | 0.19 | -0.61 | | | Diluted EPS from Continuing Operations | 0.17 | 0.65 | -1.55 | 0.18 | -0.61 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | 0.17 | 0.65 | -1.55 | 0.18 | -0.61 | | | |
